Otsuka Pays Up to $1.1B to Buy Jnana, Adds Drug Discovery Capabilities

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 01, 2024 at 11:42: AM
via With an upfront $800 million payment and $325 million in potential milestones, Otsuka Pharmaceutical is acquiring Jnana Therapeutics’ drug discovery platform and rare disease candidate, the companies announced Thursday.

article source
 

<



Similar threads

cafead
Why Otsuka launched a digital health company
Replies
0
Views
57
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Otsuka defies digital health downturn with new company
Replies
0
Views
75
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Otsuka and Lundbeck report data from three PTSD treatment trials
Replies
0
Views
94
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Otsuka Drops Alzheimer’s Agitation Drug Following Phase III Failure
Replies
0
Views
79
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Otsuka Drug Candidate Fails Phase III Alzheimer’s Agitation Study
Replies
0
Views
88
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote